Salivary Methotrexate as a Predictor of Oral Mucositis in Hematological Cancer Patients: A Phase II Randomized, Double-Blind Clinical Trial.
- DOI
- 10.1111/odi.70381
- Published
- 2026 Jul 12
- Container
- Oral diseases
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/odi.70381,
title = {Salivary Methotrexate as a Predictor of Oral Mucositis in Hematological Cancer Patients: A Phase II Randomized, Double-Blind Clinical Trial.},
author = {Rodrigues-Oliveira L and Bonfim CG and Mores AL and Palmier NR and Abdalla HB and Clemente-Napimoga JT and Aquino IG and de Oliveira MCQ and Cuzzullin MC and Filho AJV and Rivera C and Toporcov TN and Pereira J and Gueiros LA and López RVM and Martins MD and Lamers ML and Morais-Faria K and Vargas PA and Santos-Silva AR and Brandão TB and Prado-Ribeiro AC},
year = {2026},
journal = {Oral diseases},
doi = {10.1111/odi.70381},
url = {https://doi.org/10.1111/odi.70381}
}RIS
TY - JOUR TI - Salivary Methotrexate as a Predictor of Oral Mucositis in Hematological Cancer Patients: A Phase II Randomized, Double-Blind Clinical Trial. AU - Rodrigues-Oliveira L AU - Bonfim CG AU - Mores AL AU - Palmier NR AU - Abdalla HB AU - Clemente-Napimoga JT AU - Aquino IG AU - de Oliveira MCQ AU - Cuzzullin MC AU - Filho AJV AU - Rivera C AU - Toporcov TN AU - Pereira J AU - Gueiros LA AU - López RVM AU - Martins MD AU - Lamers ML AU - Morais-Faria K AU - Vargas PA AU - Santos-Silva AR AU - Brandão TB AU - Prado-Ribeiro AC PY - 2026 JO - Oral diseases DO - 10.1111/odi.70381 UR - https://doi.org/10.1111/odi.70381 ER -
APA
L, R., CG, B., AL, M., NR, P., HB, A., JT, C., IG, A., MCQ, D. O., MC, C., AJV, F., C, R., TN, T., J, P., LA, G., RVM, L., MD, M., ML, L., K, M., PA, V., AR, S., TB, B., & AC, P. (2026). Salivary Methotrexate as a Predictor of Oral Mucositis in Hematological Cancer Patients: A Phase II Randomized, Double-Blind Clinical Trial.. Oral diseases. https://doi.org/10.1111/odi.70381
Source records
- pubmed · retrieved 2026-09-26T08:10:30.079Z